Bio-engineered Stent Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026 REPORT DESCRIPTION Bio-engineered Stent Market – Overview Bio-engineered stent plays a major role in modern healthcare as it expands the blood vessel to prevent a blockage of arteries in cardiovascular diseases such as coronary heart disease and ischemic heart disease. The global bio-engineered stent market size was valued at US$ 2,764.2 million in 2017, and is projected to exhibit a CAGR of 8.7% over the forecast period (2018 – 2026). Bio-engineered stent is used in treating blockage of coronary and peripheral artery, which is related to coronary heart disease, ischemic heart disease, and other cardiovascular diseases. High prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to propel demand for bio-engineered stent, which in turn is expected to drive the market growth. According to American Heart Association, in 2018, around 92.1 million people in the U.S. were suffering with some form of cardiovascular diseases or the after-effects of stroke. Moreover, around 836,546 deaths in the U.S. were due to cardiovascular diseases, which accounted for 1 in every 3 deaths in the country. Direct and indirect costs in the treatment of cardiovascular diseases and stroke in the country were estimated to be around US$ 329.7 billion in 2018, which includes both health expenditures and lost productivity. REPORT DESCRIPTION Bio-engineered Stent Market – Dynamics Increasing prevalence of renal diseases is a major factor driving bio-engineered stents market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death worldwide, accounting for over 17.9 million deaths annually and this number is expected to increase to over 23.6 million by 2030. According to the same source, cardiovascular diseases accounted for around 836,546 deaths in the U.S. in 2015, which accounted for around 1 in every 3 deaths. Moreover, key players in the market are focused on adopting various strategies such as new Product Type launch and approvals and partnerships and collaborations to increase their foothold in the market. For instance, in May 2017, Medtronic plc., received the U.S. Food and Drug Administration (FDA) approval and Resolute Onyx, 4.5 MM and 5 mm sizes Drug-Eluting Stent. This device has proven clinical performance and superior deliverability of the Resolute Integrity. This device is intended to treat people with coronary artery disease in the U.S. Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2484 REPORT DESCRIPTION Bio-engineered Stent Market – Key Players • • • • • • • • • • Medtronic, plc. Boston Scientific Corporation Abbott Laboratories Biotronik SE & Co. KG B. Braun Melsungen AG Terumo Corporation MicroPort Scientific Corporation Stentys Sao Meril Life Sciences Pvt. Ltd Vascular Concepts Read More @ https://www.coherentmarketinsights.com/market-insight/bio-engineered-stent-market-2484 ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an ofce at the global fnancial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We ofer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES CUSTOMIZED RESEARCH SYNDICATED RESEARCH CONSULT STUDIES COUNTRY SPECIFIC STUDIES ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY MEDICAL DEVICES     CLINICAL DIAGNOSTIC MEDICAL IMAGING Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry  Private and Government organization  Outsourcing Companies  Universities and Business Schools. HEALTHCARE IT PHARMACEUTICAL ABOUT US KEY STATS 100 + 150+ RESEARCH SOLUTIONS FEASIBILITY STUDIES GLOBAL REPORTS Insights Published Per Year Consulting Projects Till Date 125+ Clients Worldwide Per Year 110+ COUNTRY ANALYSIS CONSULT PROJECTS SURVEY RESEARCH EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at ofering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

Bio-engineered stent plays a major role in modern healthcare as it expands the blood vessel to prevent a blockage of arteries in cardiovascular diseases such as coronary heart disease and ischemic heart disease. The global bio-engineered stent market size was valued at US$ 2,764.2 million in 2017, and is projected to exhibit a CAGR of 8.7% over the forecast period (2018 – 2026).